YZY Bio
About:
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies.
Website: http://yzybio.com
Top Investors: BGI Co-Win, Wuhan Institute of Biotechnology, Sanhua Hongdao Investment, TD Capital
Description:
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.
Total Funding Amount:
450M CNY
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Wuhan, Hubei, China
Founded Date:
2010-07-01
Contact Email:
info(AT)yzybio.com
Founders:
Pengfei Zhou
Number of Employees:
51-100
Last Funding Date:
2022-07-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai